Leo Pharma's label extension wish granted
![Photo: MAGNUS MØLLER](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14513492.ece/ALTERNATES/schema-16_9/doc7n9j91wh25u1bh58unr6.jpg)
Since receiving a recommendation for approval from the Committee for Medicinal Products for Human Use (CHMP) in September, Leo Pharma has been waiting for the formal approval from the EU Commission to market drug candidate Adtralza (tralokinumab) to a larger group of patients.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Dupixent might halt "the atopic march," research finds
For subscribers